Affinity DataKi: 4.32E+3nMAssay Description:Reversible inhibition of human CES1 assessed as hydrolysis of 4NPA to 4NPMore data for this Ligand-Target Pair
Affinity DataKi: 2.48E+4nMAssay Description:Reversible inhibition of human CES1 assessed as hydrolysis of 4NPA to 4NPMore data for this Ligand-Target Pair
Affinity DataKi: 3.55E+5nMAssay Description:Reversible inhibition of human CES1 assessed as hydrolysis of 4NPA to 4NPMore data for this Ligand-Target Pair
Affinity DataKi: 3.63E+5nMAssay Description:Inhibition of human CES1More data for this Ligand-Target Pair
Affinity DataKi: 4.68E+5nMAssay Description:Reversible inhibition of human CES1 assessed as hydrolysis of 4NPA to 4NPMore data for this Ligand-Target Pair
Affinity DataKi: 7.07E+5nMAssay Description:Reversible inhibition of human CES1 assessed as hydrolysis of 4NPA to 4NPMore data for this Ligand-Target Pair
Affinity DataKi: 7.90E+6nMAssay Description:Inhibition of human CES2More data for this Ligand-Target Pair
Affinity DataIC50: 1.96E+3nMAssay Description:Time-dependent inhibition of human CES1 assessed as hydrolysis of 4NPA to 4NP preincubated for 30 mins followed by 4NPA additionMore data for this Ligand-Target Pair
Affinity DataIC50: 2.27E+3nMAssay Description:Time-dependent inhibition of human CES1 assessed as hydrolysis of 4NPA to 4NP preincubated for 60 mins followed by 4NPA additionMore data for this Ligand-Target Pair
Affinity DataIC50: 2.51E+3nMAssay Description:Time-dependent inhibition of human CES1 assessed as hydrolysis of 4NPA to 4NP preincubated for 10 mins followed by 4NPA additionMore data for this Ligand-Target Pair